Self-reported hepatitis C virus antibody status and risk behavior in young injectors (Q27478003)

4

object named as

Steffanie Strathdee

0 references

author name string

Jennifer Campbell

2

0 references

Hanne Thiede

3

0 references

Lawrence Ouellet

5

0 references

Farzana Kapadia

6

0 references

Sharon Hudson

7

0 references

Richard S Garfein

8

0 references

language of work or name

English

0 references

publication date

2006

1 reference

Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention

published in

Public Health Reports

0 references

volume

121

0 references

issue

6

0 references

page(s)

710-9

0 references

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1781913

Testing for hepatitis C virus infection should be routine for persons at increased risk for infection

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1781913

Management of chronic hepatitis C virus infection: a new era of disease control

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1781913

Lack of evidence of sexual transmission of hepatitis C among monogamous couples: results of a 10-year prospective follow-up study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1781913

Monitoring hepatitis C virus infection among injecting drug users in the European Union: a review of the literature

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1781913

Methadone treatment and HIV and hepatitis B and C risk reduction among injectors in the Seattle area

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1781913

Continued transmission of hepatitis B and C viruses, but no transmission of human immunodeficiency virus among intravenous drug users participating in a syringe/needle exchange program

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1781913

Cost-effectiveness of screening patients for hepatitis C.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1781913

Accuracy of perceptions of hepatitis B and C status: cross sectional investigation of opiate addicts in treatment

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1781913

Efficacy of risk-reduction counseling to prevent human immunodeficiency virus and sexually transmitted diseases: a randomized controlled trial. Project RESPECT Study Group

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1781913

Once more unto the breach: controlling hepatitis C in injecting drug users

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1781913

Methadone maintenance and hepatitis C virus infection among injecting drug users

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1781913

The Brief Symptom Inventory: an introductory report.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1781913

Hepatitis C virus transmission dynamics in injection drug users

2 June 2018

1 reference

https://api.crossref.org/works/10.1177%2F003335490612100611

Syringe exchange and risk of infection with hepatitis B and C viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F003335490612100611

Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F003335490612100611

The association between knowledge of hepatitis C virus status and risk behaviors in injection drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F003335490612100611

HIV and hepatitis C virus risk in new and longer-term injecting drug users in Oslo, Norway

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F003335490612100611

Lack of behavior change after disclosure of hepatitis C virus infection among young injection drug users in Baltimore, Maryland

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F003335490612100611

Hepatitis C virus seroconversion among young injection drug users: relationships and risks

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F003335490612100611

Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F003335490612100611

Hepatitis C and its risk management among drug injectors in London: renewing harm reduction in the context of uncertainty

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F003335490612100611

Screening for hepatitis C virus infection in adults: recommendation statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F003335490612100611

Gaps in the drug-free and methadone treatment program response to Hepatitis C.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1781913

Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. Centers for Disease Control and Prevention.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1781913

Sharing of drug preparation equipment as a risk factor for hepatitis C

27 November 2018

1 reference

12 December 2020

Concurrence of drug users' self-report of current HIV status and serotest results

1 reference

12 December 2020

"Informed altruism" and "partner restriction" in the reduction of HIV infection in injecting drug users entering detoxification treatment in New York City, 1990-2001

1 reference

12 December 2020

Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program

1 reference

12 December 2020

Incidence rate and risk factors for HCV seroconversion among injecting drug users in an area with low HIV seroprevalence

1 reference

12 December 2020

Effects of HIV counseling and testing on sexual risk behavior: a meta-analytic review of published research, 1985-1997

1 reference

12 December 2020